Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema

Purpose. The aim of this study was to assess the effect of intravitreal injections (IVI) of ranibizumab and aflibercept on the choroidal thickness (CT) in patients with treatment-naive diabetic macular edema (DME) before and after monthly IVI. Patients and Methods. Prospective monocenter study. Incl...

Full description

Bibliographic Details
Main Authors:	Valérie Sarda, Pauline Eymard, Linda Hrarat, Franck Fajnkuchen, Audrey Giocanti-Aurégan
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2020/5708354

Similar Items

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
by: Antoine Herbaut, et al.
Published: (2017-01-01)

Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting
by: Anne-Laurence Best, et al.
Published: (2018-01-01)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
by: Sam Razavi, et al.
Published: (2021-02-01)

Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion
by: Sylvia Nghiem-Buffet, et al.
Published: (2018-01-01)

Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018-05-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
by: Norihiro Shimizu, et al.
Published: (2017-01-01)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
by: Lim LS, et al.
Published: (2015-09-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice.
by: Pablo Plaza-Ramos, et al.
Published: (2019-01-01)

Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021-01-01)

Subfoveal choroidal thickness in diabetic macular edema
by: Mohamed DM, et al.
Published: (2019-05-01)

CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: Amash Aqil, et al.
Published: (2021-04-01)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
by: Alsaedi NG, et al.
Published: (2021-07-01)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
by: Kim M, et al.
Published: (2013-11-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Effect of intravitreal injection of Ranibizumab on choroid in patients with severe NPDR with macular edema
by: Fu-Qin Du, et al.
Published: (2017-11-01)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
by: Azuma K, et al.
Published: (2018-08-01)

Aflibercept compared with dexamethasone in diabetic macular edema
by: Rodolfo Garretón, et al.
Published: (2021-05-01)

The clinical utility of aflibercept for diabetic macular edema
by: Stewart MW
Published: (2015-09-01)

The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015-08-01)

Intravitreal injection of Ranibizumab treating noninfectious uveitic macular edema
by: Hong-Bin Xie, et al.
Published: (2018-09-01)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ki Won Jin, et al.
Published: (2021-07-01)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema.
by: Tomoyasu Shiraya, et al.
Published: (2017-01-01)

Comparison of the efficacy of aflibercept and ranibizumab after a 3-month loading dose in patients with diabetic macular edema
by: Murat Çakmaklıoğulları, et al.
Published: (2021-03-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Relationship between diabetic macular edema and choroidal layer thickness.
by: Hiroaki Endo, et al.
Published: (2020-01-01)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
by: Cai S, et al.
Published: (2018-10-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

Coats’ Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation
by: Wen-Shi Shieh, et al.
Published: (2017-01-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01)

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
by: Shinichiro Chujo, et al.
Published: (2020-09-01)

Efficacy of macular focal/grid laser photocoagulation with Ranibizumab for diabetic macular edema
by: Hong-Miao Ren, et al.
Published: (2018-06-01)

Occult choroidal neovascularization after successful macular hole surgery treated with ranibizumab
by: Oh HN, et al.
Published: (2012-08-01)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
by: Mohamed A. Hamid, et al.
Published: (2021-04-01)

Full thickness macular hole following intravitreal ranibizumab injection for diabetic macular edema; a rare complication or coincidence?
by: Hasan Basri Arifoglu, et al.
Published: (2015-01-01)

Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema
by: Takao Hirano, et al.
Published: (2021-02-01)

Efficacy and safety of intravitreal aflibercept therapy in diabetic macular edema
by: Ali Cihat Aslan, et al.
Published: (2019-06-01)

Aflibercept for macular edema after branch retinal vein occlusion
by: Mahmoud Abouhussein
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_q5vnbeile0ndvokisda0l099of